Events
ASN – the American Society of Nephrology 2025
5-9 November 2025
Houston, Texas
ENYO Pharma will attend the world’s premier nephrology meeting of the American Society of Nephrology, ASN.
The 2025 International Workshop on Alport Syndrome
5-7 September 2025
Beijing, China
ENYO Pharma will attend The 2025 International Workshop on Alport Syndrome, organized by Alport Syndrome Alliance.
It is an opportunity for the Alport community to connect, update and discuss the latest research.
ENYO Pharma will meet patients and their families to present its ongoing Phase 2 “ALPESTRIA-1” clinical study with Vonafexor in Alport syndrome patients.
Alport Connect 2025 Meeting
19-20 July, 2025
Chicago, IL
ENYO Pharma is sponsoring and will attend Alport Connect 2025 organized by the American Alport Syndrome Foundation (ASF), the Alport syndrome patient-led non-profit organization in the US.
ENYO Pharma will meet patients and their families to present its ongoing Phase 2 “ALPESTRIA-1” clinical study with Vonafexor in Alport syndrome patients.
BIO International Convention
16-19 June, 2025
Boston, MA
ENYO Pharma will attend the the BIO International Convention, the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with 20,000 industry leaders from across the globe.
https://convention.bio.org/bio-2025
7th CKD Summit – Chronic Kidney Disease Drug Development
17-19 March, 2025
Boston, MA
ENYO Pharma will attend the 7th Chronic Kidney Disease Drug Development Summit, an industry forum sharing cross-industry insight to bring effective therapies to patients suffering from kidney diseases expanding also to rare renal disorders.
https://ckd3-summit.com/
Latest Press Release 